ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
83 hedge funds and large institutions have $140M invested in Aralez Pharmaceuticals Inc. in 2016 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
44% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 27
52% less call options, than puts
Call options by funds: $1.03M | Put options by funds: $2.16M
Holders
83
Holding in Top 10
4
Calls
$1.03M
Puts
$2.16M
Top Buyers
| 1 | +$3.04M | |
| 2 | +$2.23M | |
| 3 | +$1.82M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.46M |
| 5 |
D.E. Shaw & Co
New York
|
+$870K |
Top Sellers
| 1 | -$5.29M | |
| 2 | -$4.51M | |
| 3 | -$2.74M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$1.82M |
| 5 |
Renaissance Technologies
New York
|
-$1.78M |